Vivet Therapeutics
company
About
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- €45M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.Vivet Therapeutics is focused on optimizing gene therapy through a partnership with the Fundacion para la Investigacion Medica Aplicada (FIMA) at the Centro de Investigación Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€45M
Vivet Therapeutics has raised a total of
€45M
in funding over 2 rounds. Their latest funding was raised on
Mar 20, 2019 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2019 | Corporate Round | €45M | 1 |
Pfizer
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Vivet Therapeutics is funded by 1 investors.
Pfizer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pfizer
|
Yes | Corporate Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
